These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor. Palii SS; Afzal A; Shaw LC; Pan H; Caballero S; Miller RC; Jurczyk S; Reubi JC; Tan Y; Hochhaus G; Edelhauser H; Geroski D; Shapiro G; Grant MB Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5094-102. PubMed ID: 18599562 [TBL] [Abstract][Full Text] [Related]
23. SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model. Singh SP; Han L; Murali R; Solis L; Roth J; Ji L; Wistuba I; Kundra V Hum Gene Ther; 2011 Jan; 22(1):55-64. PubMed ID: 20653396 [TBL] [Abstract][Full Text] [Related]
24. Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells. Parry JJ; Eiblmaier M; Andrews R; Meyer LA; Higashikubo R; Anderson CJ; Rogers BE Mol Imaging; 2007; 6(1):56-67. PubMed ID: 17311765 [TBL] [Abstract][Full Text] [Related]
25. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice. Weckbecker G; Raulf F; Bodmer D; Bruns C Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482 [TBL] [Abstract][Full Text] [Related]
26. Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors. Streuli J; Harris AG; Cottiny C; Allagnat F; Daly AF; Grouzmann E; Abid K Neuropeptides; 2018 Apr; 68():84-89. PubMed ID: 29523357 [TBL] [Abstract][Full Text] [Related]
27. A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake. Kölby L; Bernhardt P; Ahlman H; Wängberg B; Johanson V; Wigander A; Forssell-Aronsson E; Karlsson S; Ahrén B; Stenman G; Nilsson O Am J Pathol; 2001 Feb; 158(2):745-55. PubMed ID: 11159212 [TBL] [Abstract][Full Text] [Related]
28. Preclinical evaluation of [99mTc/EDDA/tricine/HYNIC0, 1-Nal3, Thr8]-octreotide as a new analogue in the detection of somatostatin-receptor-positive tumors. Gandomkar M; Najafi R; Shafiei M; Mazidi M; Ebrahimi SE Nucl Med Biol; 2007 Aug; 34(6):651-7. PubMed ID: 17707805 [TBL] [Abstract][Full Text] [Related]
29. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis. Imhof AK; Glück L; Gajda M; Lupp A; Bräuer R; Schaible HG; Schulz S Arthritis Rheum; 2011 Aug; 63(8):2352-62. PubMed ID: 21506098 [TBL] [Abstract][Full Text] [Related]
30. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro. Weckbecker G; Liu R; Tolcsvai L; Bruns C Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289 [TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney. Rolleman EJ; Kooij PP; de Herder WW; Valkema R; Krenning EP; de Jong M Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1854-60. PubMed ID: 17546456 [TBL] [Abstract][Full Text] [Related]
33. A tyrosine phosphatase is associated with the somatostatin receptor. Delesque N; Buscail L; Estève JP; Rauly I; Zeggari M; Saint-Laurent N; Bell GI; Schally AV; Vaysse N; Susini C Ciba Found Symp; 1995; 190():187-96; discussion 196-203. PubMed ID: 7587647 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma. Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186 [TBL] [Abstract][Full Text] [Related]
36. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals. Wild D; Schmitt JS; Ginj M; Mäcke HR; Bernard BF; Krenning E; De Jong M; Wenger S; Reubi JC Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1338-47. PubMed ID: 12937948 [TBL] [Abstract][Full Text] [Related]
37. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Sharma K; Patel YC; Srikant CB Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277 [TBL] [Abstract][Full Text] [Related]